Clinical trial NCT05133219: The Effect of ıntensified Sensory-based Therapy on Upper Extremity Functions and Activities of Daily Living
Official title: The Effect of ıntensified Sensory-based Therapy on Upper Extremity Functions and Activities of Daily Living in Patients With Chronic Stroke
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Stroke
Sensory Defect
Lead sponsor: Kocaeli University
Sponsor class: OTHER
First posted: 2021-11-24
Enrollment: 30
Sex: ALL
Minimum age (years): 18
Maximum age (years): 80
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Sensory dysfunction following stroke is a common condition. The deficiency in the somatosensory system negatively affects the learning of new motor skills by preventing feedback from the sensory system, and it can also cause problems in daily life, personal care, productivity, and leisure activities. Somatosensory impairment is often overlooked, as rehabilitation often focuses on motor abilities in the affected extremity. In the studies reviewed, it is stated that sensory dysfunction is seen in approximately 50% of stroke patients.

The aim of this study is to examine the effects of intensified sensory-based therapy applied to the affected upper extremity sensory functions in individuals with chronic stroke on the upper extremity functions, quality of life, and independence of daily living activities.

Detailed description: Sensory dysfunction following stroke is a common condition. The deficiency in the somatosensory system negatively affects the learning of new motor skills by preventing feedback from the sensory system, and it can also cause problems in daily life, personal care, productivity, and leisure activities. Somatosensory impairment is often overlooked, as rehabilitation often focuses on motor abilities in the affected extremity. In the studies reviewed, it is stated that sensory dysfunction is seen in approximately 50% of stroke patients.

The aim of the study; The aim of this study is to examine the effects of intensified sensory-based therapy applied to the affected upper extremity sensory functions in individuals with chronic stroke on the upper extremity functions, quality of life, and independence of daily living activities.

Thirty patients with chronic stroke will be randomized 1:1 to study (n:15) and control (n=12). Thumb localization test, finger swipe test, stereognosis test, and two-point discrimination test will be used to evaluate the sensory functions of individuals. Demographic information of individuals will be recorded with a sociodemographic information form. Before the treatment, the sensory levels of all patients will be determined by thumb localization, finger scrolling and stereognosy tests. Jebsen Taylor Hand Function Test (JTHFT), Modified Frenchay Scale (MFS), Canadian Occupational Performance Measure (COPM), Goal Attainment Scale (GAS) and Stroke-Specific Quality of Life Scale (SSQOL) will be administered before and after treatment.

Eligibility criteria: Inclusion Criteria:

* Stroke duration more than 6 months,
* To be able to communicate
* 10 degrees of wrist dorsiflexion starting from full palmar flexion of the wrist
* To initiate finger extension

Exclusion Criteria:

* Joint contracture in the upper and lower extremities that will affect functionality other than stroke,
* Having a significant uncontrolled health problem and a history of epileptic seizures,
* Having 3 or more spasticity according to the Modified Ashworth Scale (MAS),
* Unable to communicate and cooperate,
* With marked ataxia and dystonia,
* Lack of movement and function in the wrist and fingers
* Having a diagnosis of bilateral stroke

Primary outcomes:
measure: Canadian Occupational Performance Measure (COPM)- Satisfaction
timeFrame: 3 weeks
measure: Canadian Occupational Performance Measure (COPM)- Performance
timeFrame: 3 weeks
measure: Jebsen Taylor Hand Function Test (JTHFT)
timeFrame: 3 weeks
measure: The Modified Frenchay Scale (MFS)
timeFrame: 3 weeks
Secondary outcomes:
measure: The Stroke Specific Quality Of Life Scale (SSQOL)
timeFrame: 3 weeks
measure: Sensory Test- Stereognosy Test
timeFrame: 3 weeks
measure: Sensory Test- Finger Shift Test
timeFrame: 3 weeks
measure: Sensory Test- Thumb Localization Test
timeFrame: 3 weeks
measure: Goal Attainment Scaling (GAS)
timeFrame: 3 weeks
Other outcomes:
Locations:
city: Kocaeli
country: Turkey
facility: Kocaeli Üniversitesi
Study officials:
affiliation: Kocaeli University
name: Çiğdem ÇEKMECE, PhD
role: STUDY_CHAIR
References: